Prøve GULL - Gratis

3 trends to drive and shape the future of digital health

BioSpectrum Asia

|

BioSpectrum Asia July 2021

A year on, the effects of the COVID-19 pandemic on the world continue to be profound. More than 90 per cent of global executives polled by McKinsey and Company believe COVID-19 will fundamentally change their businesses, and 85 per cent predict lasting changes in customers’ preferences. Being on the frontlines of the fight against COVID-19 has placed unparalleled demands on the healthcare industry no less – and quite possibly more – than any other sector.

3 trends to drive and shape the future of digital health

Chintan Desai, ASEAN CEO, GE Healthcare, Singapore

Healthcare systems across the world were initially caught off-guard when tasked with this unprecedented crisis, which required the urgent mobilisation of resources and affected the whole population.

Unfortunately, the fight is still far from over. In recent weeks, new, more contagious variants of the virus have emerged in countries such as India, the United Kingdom, and South Africa. These intractable variants have spread rapidly across the region sending countries into another round of lockdowns, outpacing the global vaccination programme determined to be the best weapon in fighting the pandemic.

Global social distancing, infection control, and lockdown measures have created a plethora of challenges for the healthcare industry as it looks to tackle the influx of patients while continuing to deliver ongoing care that remains critical. However, for an industry that thrives through constant discovery, the eventual speed and scale of its response to COVID-19 has been nothing short of remarkable.

The pandemic has proved to be a powerful catalyst in bringing forward the industry’s digitalisation. We are now seeing the convergence of digital technologies with healthcare, to make medicine more personalised and precise.

As the situation evolves, it is important we continue to invest in building new capabilities today so that we have the capacity to deal with the emergencies of tomorrow. Here are three trends I believe will permanently drive and shape the way healthcare is delivered and received, for the future of digital health.

1. Accelerating precision health by leveraging digital technology

FLERE HISTORIER FRA BioSpectrum Asia

BioSpectrum Asia

BioSpectrum Asia

Collaborative R&D: Partnerships shaping the future of biopharma

Biotechs and pharma companies face rising costs of drug development, depleting R&D pipelines and diminishing returns on investment. By joining forces and exploring collaborative R&D partnerships it is possible to overcome these challenges. In addition to sharing risks, they share the potential rewards when their assets move further into clinical development or come to the market.

time to read

2 mins

BioSpectrum Asia Sep 2025

BioSpectrum Asia

BioSpectrum Asia

Quantum Computing: Future of diagnostics is being coded today

A silent revolution is being built at the intersection of biology and quantum physics. After decades of pushing the boundaries of diagnostics with advanced imaging and AI, we are now approaching a hard computational wall. For complex conditions like Alzheimer's, Parkinson's, and many cancers, the interacting variables of genomics, proteomics, and real-world patient data are simply too vast for classical computers to master. This limitation caps the ability to move from merely spotting correlations to uncovering true causation. Unlike traditional AI, quantum computing can simulate underlying physical systems to derive precise solutions. The transition from correlational analysis to causal simulation will enable a more valuable and advanced frontier in diagnostics.

time to read

4 mins

BioSpectrum Asia Sep 2025

BioSpectrum Asia

First Pacific woman to serve as public health director in NZ

The Ministry of Health in New Zealand (NZ) has appointed Dr Corina Grey as the new Director of Public Health this year, a landmark appointment for Pacific leadership.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

Bio-Rad appoints Rajat Mehta as Executive Vice President of Global Commercial Operations

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, has announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial Operations, effective August 4, 2025.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

BioSpectrum Asia

Hugel launches botulinum toxin Letybo in Malaysia

South Korea-based Hugel Inc., a leading global medical aesthetics company, has officially launched its botulinum toxin product Letybo in Malaysia - an emerging market for medical aesthetics in Southeast Asia.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

BioSpectrum Asia

Australia designs smart wound monitor to improve chronic infection care

Researchers from Australia's RMIT University have developed a wearable wound monitoring device with integrated sensors that could reduce infection risks by minimising the need for frequent physical contact.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

Revvity unveils innovative reagent technology to accelerate therapeutics development

US-based Revvity, Inc. has announced the launch of pHSense reagents, a powerful technology designed to advance internalisation studies in drug discovery.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

BioSpectrum Asia

Sanofi acquires next-gen vaccine biotech Vicebio for $1.6 B

Vicebio, a biopharmaceutical company with operations in Australia, UK and Belgium, has entered an exclusive, definitive agreement to be acquired by Sanofi.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

HOSMAC signs MoU with Gulf Medical University to strengthen healthcare education

HOSMAC, Asia's leading hospital planning, design, and management consultancy, has signed a Memorandum of Understanding (MoU) with Gulf Medical University (GMU), Ajman, UAE, to serve as an industry partner.

time to read

1 min

BioSpectrum Asia Sep 2025

BioSpectrum Asia

Jessica Cowden takes charge as Deputy Director General of CARE unit at IVI

Dr Jessica Cowden has been appointed Deputy Director General of the Clinical, Assessment, Regulatory, Evaluation (CARE) unit at South Korea-headquartered International Vaccine Institute (IVI). She will continue to be based at IVI's Europe Regional Office in Stockholm, Sweden.

time to read

1 min

BioSpectrum Asia Sep 2025

Translate

Share

-
+

Change font size